MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20183156

March 14, 2023

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

0.05%(150ml:75mg)

化学药品

March 14, 2023

Company Information

Applicant Company

海口市南海大道273号海口高新区D栋轻钢结构标准工业厂房西侧

Manufacturing Company

海口市南海大道273号海口高新区D栋轻钢结构标准工业厂房西侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath